Hunan Hansen Pharmaceutical Co., Ltd.

¥7.71As of Sun 8 Nov 2026, 12:00 UTC
SZSE:002412Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR (2.25%)
Div yield 3.89%
ROE 11.69%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.51
PE TTM 14.27
TSR TTM 26.81%
Mkt cap ¥3.880B
ROIC 10.49%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥8.14
5.63%
(65.00%)
Sell 7|9|8|0|3
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.10
0.10
0.10
0.11
4.08%
2.05%
1.95%
3.05%
Revenue¥M
295.2
295.9
303.9
307.6
0.23%
2.06%
7.62%
3.15%
Peers (US$581.6M)
Cap (US$)
PE
575.6M
26.66x
Capital
TTM
5Y
10Y
Leveragex
0.061
0.021
0.023
EBIT/Intx
0.289
0.120
0.131
Own earn%
(45.29)
26.32
20.50
Sh yield%
39.81
18.51
18.84
Owners
Insiders/Inst%
7.05
51.48
Short interest%
1.81
SBC / revenue%
5.19
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
20
Op margin range%
14–23
$1 testx
—
Incr. ROIC%
24